These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17094654)

  • 1. [Peptide mapping of the monoclonal antibodies against the heavy chain hemagglutinin from influenza virus H3N2].
    Mazurkova NA; Isaeva EI; Podcherniaeva RIa
    Mol Gen Mikrobiol Virusol; 2006; (4):19-23. PubMed ID: 17094654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin.
    Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E
    Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.
    Shibuya T; Yamashiro T; Masaike Y; Ohuchi M; Uechi G; Nishizono A
    Microbiol Immunol; 2008 Mar; 52(3):162-70. PubMed ID: 18402598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry.
    Morrissey B; Streamer M; Downard KM
    J Virol Methods; 2007 Nov; 145(2):106-14. PubMed ID: 17588679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic and biochemical features of a monoclonal antibody heavy chain, JN1-2, raised against a synthetic peptide with a hemagglutinin molecule of influenza virus.
    Hifumi E; Takao S; Fujimoto N; Uda T
    J Am Chem Soc; 2011 Sep; 133(38):15015-24. PubMed ID: 21861493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic and genetic study of influenza virus circulated in China in 2006].
    Zhang Y; Zhao X; Guo JF; Wei HJ; Cheng YH; Li XW; Xu CL; Guo YJ; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):304-6. PubMed ID: 18322584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
    Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
    Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.
    Wang W; Butler EN; Veguilla V; Vassell R; Thomas JT; Moos M; Ye Z; Hancock K; Weiss CD
    J Virol Methods; 2008 Nov; 153(2):111-9. PubMed ID: 18722473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of envelope antigens of influenza A (H3N2) virus isolated during 1983-1985 epidemics and from sporadic cases of infection.
    Stumpa A; Tůmová B; Luther P
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):173-80. PubMed ID: 3411119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.
    Stelzer-Braid S; Wong B; Robertson P; Lynch GW; Laurie K; Shaw R; Barr I; Selleck PW; Baleriola C; Escott R; Katsoulotos G; Rawlinson WD
    J Clin Virol; 2008 Oct; 43(2):241-3. PubMed ID: 18675584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characterization of influenza viruses by the immunoperoxidase method using monoclonal antibodies. Its setup and validation].
    Oropesa Fernández S; Morier Díaz L; Vázquez Ramudo S; Goyenechea Hernández A; Valdivia Romero A; Hernández Espinosa B; García Infante S
    Rev Cubana Med Trop; 1996; 48(3):149-54. PubMed ID: 9805039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.
    Nakagawa N; Suzuoki J; Kubota R; Kobatake S; Okuno Y
    J Clin Microbiol; 2006 Apr; 44(4):1564-6. PubMed ID: 16597895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An indirect sandwich ELISA for the detection of avian influenza H5 subtype viruses using anti-hemagglutinin protein monoclonal antibody.
    Luo Q; Huang H; Zou W; Dan H; Guo X; Zhang A; Yu Z; Chen H; Jin M
    Vet Microbiol; 2009 May; 137(1-2):24-30. PubMed ID: 19136223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody.
    Vanlandschoot P; Beirnaert E; Dewilde S; Saelens X; Bestebroer T; De Jong J; Jou WM; Fiers W
    Virology; 1995 Oct; 212(2):526-34. PubMed ID: 7571422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
    Lipatov AS; Gitelman AK; Smirnov YuA
    Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic properties of synthetic fragments of the heavy chain of influenza virus A hemagglutinin].
    Samukov VV; Mazurkova NA; Kalashnikov VV; Ofitserov VI; Shval'e AF
    Mol Gen Mikrobiol Virusol; 1988 Jul; (7):35-9. PubMed ID: 2461511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003.
    Okada J; Ohshima N; Kubota-Koketsu R; Ota S; Takase W; Azuma M; Iba Y; Nakagawa N; Yoshikawa T; Nakajima Y; Ishikawa T; Asano Y; Okuno Y; Kurosawa Y
    Virology; 2010 Feb; 397(2):322-30. PubMed ID: 19969317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.